Lexaria Bioscience Corp (LEXXW) — Strategic Asset Allocation Index
Lexaria Bioscience Corp (LEXXW) has a Strategic Asset Allocation Index of 29.2% as of November 2020. Strategic assets (PP&E of $532.51K plus long-term investments of $-) total $532.51K, measured against net assets of $1.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Lexaria Bioscience Corp liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Lexaria Bioscience Corp Strategic Asset Allocation Index (2016–2020)
This chart shows how Lexaria Bioscience Corp's Strategic Asset Allocation Index has evolved across 5 annual periods from 2016 to 2020. As of November 2020, the index stands at 29.2%, representing strategic assets of $532.51K against net assets of $1.82 Million USD. See Lexaria Bioscience Corp leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Lexaria Bioscience Corp (2016–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Lexaria Bioscience Corp from 2016 to 2020, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see LEXXW company net worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 24.6% | $610.28K | $610.28K | $- | $2.48 Million | ▲ +0.8 pp |
| 2019 | 23.7% | $591.26K | $591.26K | $- | $2.49 Million | ▲ +23.7 pp |
| 2018 | 0.1% | $1.24K | $1.24K | $- | $2.39 Million | ▼ 0.0 pp |
| 2017 | 0.1% | $1.86K | $1.86K | $- | $2.77 Million | ▼ -2.8 pp |
| 2016 | 2.8% | $2.48K | $2.48K | $- | $87.76K | — |